Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE): Quality and safety in the implementation of medicinal cannabis use in the community

澳大利亚有世界上第一个机会在高质量的临床和环境科学的基础上开展严格的医用大麻研究，测试和选择影响健康和疾病的大麻成分。它将能够设计和协调剂量和配方研究，以评估不同大麻素的安全性和有效性。这些信息将使经过彻底研究和测试达到公众使用可接受水平的保健产品得以注册。

Australia has a world-first opportunity to develop rigorous medical cannabis research based on quality clinical and environmental science that tests and selects cannabis constituents affecting health and sickness. It will be able to design and coordinate dose and formulation-finding studies to assess safety and efficacy of different cannabinoids. This information will enable registration of products for health that have been thoroughly researched and tested to levels acceptable for public use.